| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |